Sanyou Bio Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
300
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$15M
- Investors
-
9
Sanyou Bio General Information
Description
Provider of innovative biological drug research and development services intended to accelerate the transformation of new drug pipelines. The company offers an integrated 4c business system comprising contract research, development, production and specialty services, enabling pharmaceutical clients to accelerate drug discovery through intelligent trillion-molecule libraries and cell line development platforms.
Contact Information
Website
www.sanyoubio.com.cnCorporate Office
- Building T3
- Number 559 Zhuyuan Road, Minhang District
- Shanghai, 201114
- China
Corporate Office
- Building T3
- Number 559 Zhuyuan Road, Minhang District
- Shanghai, 201114
- China
Sanyou Bio Timeline
Sanyou Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series C) | 09-Nov-2026 | $15M | Completed | Generating Revenue | ||
| 10. Secondary Transaction - Private | 11-Feb-2026 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | 12-Feb-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 01-Jan-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 08-Mar-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 26-Jun-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 30-Jun-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 15-May-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 07-Dec-2017 | Completed | Generating Revenue |
Sanyou Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sanyou Bio Patents
Sanyou Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026184053-A1 | 5t4-targeting antibody and use thereof | Pending | 06-Mar-2025 | ||
| WO-2026184052-A1 | Anti-gpc3 antibody or antigen-binding fragment thereof and use thereof | Pending | 06-Mar-2025 | ||
| WO-2026184054-A1 | Antibody targeting fcrn and use thereof | Pending | 06-Mar-2025 | ||
| WO-2026138006-A1 | Antibody targeting monkeypox virus, antigen-binding fragment thereof, and use thereof | Pending | 23-Dec-2024 | ||
| WO-2026081751-A1 | Antibody targeting trop2, antibody-drug conjugate, and use thereof | Pending | 14-Oct-2024 | C07K16/30 |
Sanyou Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sanyou Bio Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zero2IPO Fund of Funds | Limited Partner | Minority | ||
| Yanghe Investment | Venture Capital | Minority | ||
| Huatai Zijin Investment | Corporate Venture Capital | Minority | ||
| Shenzhen Qianhai Beizeng | PE/Buyout | Minority | ||
| Grand Mount Capital | Venture Capital | Minority |
Sanyou Bio FAQs
-
When was Sanyou Bio founded?
Sanyou Bio was founded in 2015.
-
Where is Sanyou Bio headquartered?
Sanyou Bio is headquartered in Shanghai, China.
-
What is the size of Sanyou Bio?
Sanyou Bio has 300 total employees.
-
What industry is Sanyou Bio in?
Sanyou Bio’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Sanyou Bio a private or public company?
Sanyou Bio is a Private company.
-
What is Sanyou Bio’s current revenue?
The current revenue for Sanyou Bio is .
-
How much funding has Sanyou Bio raised over time?
Sanyou Bio has raised $15M.
-
Who are Sanyou Bio’s investors?
Zero2IPO Fund of Funds, Yanghe Investment, Huatai Zijin Investment, Shenzhen Qianhai Beizeng, and Grand Mount Capital are 5 of 9 investors who have invested in Sanyou Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
